Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation Life Science Investing
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome Life Science Investing
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results Life Science Investing
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab Life Science Investing
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates Life Science Investing
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference Life Science Investing
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. Life Science Investing
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026 Life Science Investing
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Life Science Investing
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Life Science Investing
